GlassScriptPhysician profile
Adil M Ansari
NPI 1730366378
$9,596.23
in general payments reported to CMS, 2019-2025
13 companies · $9,188 in 2025
The $9,188 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $219 · 2024: $190 · 2025: $9,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,000 · Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,000.00 |
| Food and Beverage | $596.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,000.00 | 2025 | Xience V |
| Novo Nordisk INC | $126.64 | 2023-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $117.09 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $93.21 | 2023-2025 | Arexvy, Shingrix |
| Pfizer INC. | $80.52 | 2024-2025 | |
| Exact Sciences Corporation | $60.33 | 2023-2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.60 | 2024 | Ofev |
| Dexcom, INC. | $17.32 | 2023 | Dexcom G6 Transmitter |
| Amgen INC. | $16.77 | 2023 | Evenity, Prolia |
| Becton, Dickinson and Company | $16.44 | 2024 | Venclose Maven Catheter |
| Medtronic, INC. | $15.86 | 2023 | Venaseal |
| Abbvie INC. | $15.24 | 2023 | Vraylar |
| Janssen Pharmaceuticals, INC | $13.21 | 2024 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.